| abstract |
(57) [Summary] (Modified) [Problem] Composition to improve diseases related to nicotinic and muscarinic acetylcholine receptors, dopamine 1 receptors, benzodiazepine receptors, and GABA receptors with excellent stability, safety, and cost Offer things. A nicotinic and muscarinic acetylcholine receptor, a dopamine 1 receptor, a benzodiazepine receptor, a GABA receptor agonist, schizophrenia, Tourette's syndrome, lack of attention, containing kale, propolis or extracts thereof Composition for treatment or prevention of central nervous system diseases such as disability, anxiety, reading disorders, senile dementia, senile dementia, Parkinsonism including Parkinson's disease, Huntington's chorea, late movement abnormalities, or hyperkinesia, Brain function improving agent, brain metabolic activator, oral composition, parenteral composition, food and medicine containing these. |